IBDEI0G5 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7780,1,4,0)
 ;;=4^368.8
 ;;^UTILITY(U,$J,358.3,7780,2)
 ;;=^88172
 ;;^UTILITY(U,$J,358.3,7781,0)
 ;;=368.13^^49^562^41
 ;;^UTILITY(U,$J,358.3,7781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7781,1,3,0)
 ;;=3^Photophobia
 ;;^UTILITY(U,$J,358.3,7781,1,4,0)
 ;;=4^368.13
 ;;^UTILITY(U,$J,358.3,7781,2)
 ;;=^126851
 ;;^UTILITY(U,$J,358.3,7782,0)
 ;;=998.59^^49^562^42
 ;;^UTILITY(U,$J,358.3,7782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7782,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,7782,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,7782,2)
 ;;=^97081
 ;;^UTILITY(U,$J,358.3,7783,0)
 ;;=368.03^^49^562^5
 ;;^UTILITY(U,$J,358.3,7783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7783,1,3,0)
 ;;=3^Amblyopia,Refractive
 ;;^UTILITY(U,$J,358.3,7783,1,4,0)
 ;;=4^368.03
 ;;^UTILITY(U,$J,358.3,7783,2)
 ;;=^265363
 ;;^UTILITY(U,$J,358.3,7784,0)
 ;;=367.31^^49^562^6
 ;;^UTILITY(U,$J,358.3,7784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7784,1,3,0)
 ;;=3^Anisometropia
 ;;^UTILITY(U,$J,358.3,7784,1,4,0)
 ;;=4^367.31
 ;;^UTILITY(U,$J,358.3,7784,2)
 ;;=^7839
 ;;^UTILITY(U,$J,358.3,7785,0)
 ;;=367.20^^49^562^7
 ;;^UTILITY(U,$J,358.3,7785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7785,1,3,0)
 ;;=3^Astigmatism,NOS
 ;;^UTILITY(U,$J,358.3,7785,1,4,0)
 ;;=4^367.20
 ;;^UTILITY(U,$J,358.3,7785,2)
 ;;=^11141
 ;;^UTILITY(U,$J,358.3,7786,0)
 ;;=367.0^^49^562^31
 ;;^UTILITY(U,$J,358.3,7786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7786,1,3,0)
 ;;=3^Hypermetropia
 ;;^UTILITY(U,$J,358.3,7786,1,4,0)
 ;;=4^367.0
 ;;^UTILITY(U,$J,358.3,7786,2)
 ;;=^60139
 ;;^UTILITY(U,$J,358.3,7787,0)
 ;;=367.1^^49^562^37
 ;;^UTILITY(U,$J,358.3,7787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7787,1,3,0)
 ;;=3^Myopia
 ;;^UTILITY(U,$J,358.3,7787,1,4,0)
 ;;=4^367.1
 ;;^UTILITY(U,$J,358.3,7787,2)
 ;;=^80671
 ;;^UTILITY(U,$J,358.3,7788,0)
 ;;=V43.1^^49^562^45
 ;;^UTILITY(U,$J,358.3,7788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7788,1,3,0)
 ;;=3^Pseudophakia
 ;;^UTILITY(U,$J,358.3,7788,1,4,0)
 ;;=4^V43.1
 ;;^UTILITY(U,$J,358.3,7788,2)
 ;;=^69114
 ;;^UTILITY(U,$J,358.3,7789,0)
 ;;=367.9^^49^562^46
 ;;^UTILITY(U,$J,358.3,7789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7789,1,3,0)
 ;;=3^Refractive Error
 ;;^UTILITY(U,$J,358.3,7789,1,4,0)
 ;;=4^367.9
 ;;^UTILITY(U,$J,358.3,7789,2)
 ;;=^35634
 ;;^UTILITY(U,$J,358.3,7790,0)
 ;;=365.04^^49^562^26
 ;;^UTILITY(U,$J,358.3,7790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7790,1,3,0)
 ;;=3^Glaucoma Ocular Hypertension
 ;;^UTILITY(U,$J,358.3,7790,1,4,0)
 ;;=4^365.04
 ;;^UTILITY(U,$J,358.3,7790,2)
 ;;=^85124
 ;;^UTILITY(U,$J,358.3,7791,0)
 ;;=365.01^^49^562^30
 ;;^UTILITY(U,$J,358.3,7791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7791,1,3,0)
 ;;=3^Glaucoma Suspect
 ;;^UTILITY(U,$J,358.3,7791,1,4,0)
 ;;=4^365.01
 ;;^UTILITY(U,$J,358.3,7791,2)
 ;;=^340633
 ;;^UTILITY(U,$J,358.3,7792,0)
 ;;=365.71^^49^562^24
 ;;^UTILITY(U,$J,358.3,7792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7792,1,3,0)
 ;;=3^Glaucoma Mild Stage
 ;;^UTILITY(U,$J,358.3,7792,1,4,0)
 ;;=4^365.71
 ;;^UTILITY(U,$J,358.3,7792,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,7793,0)
 ;;=365.72^^49^562^25
 ;;^UTILITY(U,$J,358.3,7793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7793,1,3,0)
 ;;=3^Glaucoma Moderate Stage
 ;;^UTILITY(U,$J,358.3,7793,1,4,0)
 ;;=4^365.72
 ;;^UTILITY(U,$J,358.3,7793,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,7794,0)
 ;;=365.73^^49^562^28
 ;;^UTILITY(U,$J,358.3,7794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7794,1,3,0)
 ;;=3^Glaucoma Severe Stage
 ;;^UTILITY(U,$J,358.3,7794,1,4,0)
 ;;=4^365.73
 ;;^UTILITY(U,$J,358.3,7794,2)
 ;;=^340515
